Annual Operating Expenses
$127.42 M
-$1.61 M-1.25%
December 31, 2023
Summary
- As of February 8, 2025, IPSC annual total operating expenses is $127.42 million, with the most recent change of -$1.61 million (-1.25%) on December 31, 2023.
- During the last 3 years, IPSC annual operating expenses has risen by +$78.24 million (+159.10%).
- IPSC annual operating expenses is now -1.25% below its all-time high of $129.03 million, reached on December 31, 2022.
Performance
IPSC Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$35.58 M
+$54.00 K+0.15%
September 30, 2024
Summary
- As of February 8, 2025, IPSC quarterly total operating expenses is $35.58 million, with the most recent change of +$54.00 thousand (+0.15%) on September 30, 2024.
- Over the past year, IPSC quarterly operating expenses has increased by +$3.81 million (+11.98%).
- IPSC quarterly operating expenses is now at all-time high.
Performance
IPSC Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
IPSC Operating Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -1.3% | +12.0% |
3 y3 years | +159.1% | +14.9% |
5 y5 years | +536.0% | +14.9% |
IPSC Operating Expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -1.3% | +34.3% | at high | +27.2% |
5 y | 5-year | -1.3% | +536.0% | at high | +256.1% |
alltime | all time | -1.3% | +536.0% | at high | +256.1% |
Century Therapeutics Operating Expenses History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $35.58 M(+0.2%) |
Jun 2024 | - | $35.53 M(+10.5%) |
Mar 2024 | - | $32.16 M(+4.1%) |
Dec 2023 | $127.42 M(-1.3%) | $30.89 M(-2.8%) |
Sep 2023 | - | $31.77 M(+2.6%) |
Jun 2023 | - | $30.96 M(-8.4%) |
Mar 2023 | - | $33.80 M(-0.1%) |
Dec 2022 | $129.03 M | $33.83 M(-0.4%) |
Sep 2022 | - | $33.96 M(+3.7%) |
Jun 2022 | - | $32.75 M(+14.9%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2022 | - | $28.49 M(+1.9%) |
Dec 2021 | $94.88 M(+92.9%) | $27.97 M(+8.3%) |
Sep 2021 | - | $25.83 M(+12.2%) |
Jun 2021 | - | $23.02 M(+27.5%) |
Mar 2021 | - | $18.06 M(+18.4%) |
Dec 2020 | $49.18 M(+145.5%) | $15.26 M(+16.2%) |
Sep 2020 | - | $13.13 M(+21.7%) |
Jun 2020 | - | $10.79 M(+8.0%) |
Mar 2020 | - | $9.99 M |
Dec 2019 | $20.03 M | - |
FAQ
- What is Century Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Century Therapeutics?
- What is Century Therapeutics annual operating expenses year-on-year change?
- What is Century Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Century Therapeutics?
- What is Century Therapeutics quarterly operating expenses year-on-year change?
What is Century Therapeutics annual total operating expenses?
The current annual operating expenses of IPSC is $127.42 M
What is the all time high annual operating expenses for Century Therapeutics?
Century Therapeutics all-time high annual total operating expenses is $129.03 M
What is Century Therapeutics annual operating expenses year-on-year change?
Over the past year, IPSC annual total operating expenses has changed by -$1.61 M (-1.25%)
What is Century Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of IPSC is $35.58 M
What is the all time high quarterly operating expenses for Century Therapeutics?
Century Therapeutics all-time high quarterly total operating expenses is $35.58 M
What is Century Therapeutics quarterly operating expenses year-on-year change?
Over the past year, IPSC quarterly total operating expenses has changed by +$3.81 M (+11.98%)